{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T12:49:55Z","timestamp":1770727795748,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"am","delay-in-days":261,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jogoh.2022.102409","type":"journal-article","created":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T11:39:48Z","timestamp":1652528388000},"page":"102409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Interval debulking surgery after neoadjuvant chemotherapy in advanced ovarian cancer - retrospective study comparing surgery after 3 cycles or more of chemotherapy"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1461-9448","authenticated-orcid":false,"given":"Maureen Cohen","family":"Bacry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne C\u00e9cile","family":"Philippe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Riethmuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Luc","family":"Faucheron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Pomel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jogoh.2022.102409_bib0001","first-page":"284\u2011296","article-title":"\u00ab Ovarian cancer statistics, 2018 \u00bb","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 4","key":"10.1016\/j.jogoh.2022.102409_bib0002","doi-asserted-by":"crossref","first-page":"iv259","DOI":"10.1093\/annonc\/mdy157","article-title":"\u00ab Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up \u00bb","volume":"29","author":"Ledermann","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jogoh.2022.102409_bib0003","first-page":"101\u2011104","article-title":"\u00ab Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma \u00bb","volume":"42","author":"Griffiths","year":"1975","journal-title":"Natl Cancer Inst Monogr"},{"issue":"5","key":"10.1016\/j.jogoh.2022.102409_bib0004","doi-asserted-by":"crossref","first-page":"1248\u20111259","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"\u00ab Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis \u00bb","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.jogoh.2022.102409_bib0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejso.2008.01.005","article-title":"\u00ab Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients \u00bb","volume":"35","author":"Colombo","year":"2009","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.jogoh.2022.102409_bib0006","doi-asserted-by":"crossref","first-page":"1234\u20111244","DOI":"10.1002\/cncr.24149","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.jogoh.2022.102409_bib0007","doi-asserted-by":"crossref","first-page":"1689\u20111696","DOI":"10.1016\/j.ejso.2020.04.029","article-title":"\u00ab Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: A multicenter cohort analysis from the FRANCOGYN study group \u00bb","volume":"46","author":"Vincent","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.jogoh.2022.102409_bib0008","doi-asserted-by":"crossref","first-page":"629\u2011634","DOI":"10.1056\/NEJM199503093321002","article-title":"\u00ab The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer \u00bb","volume":"332","author":"van der Burg","year":"1995","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jogoh.2022.102409_bib0009","doi-asserted-by":"crossref","first-page":"1138\u20111150","DOI":"10.1200\/JCO.1991.9.7.1138","article-title":"\u00ab Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience \u00bb","volume":"9","author":"Omura","year":"1991","journal-title":"J Clin Oncol"},{"issue":"28","key":"10.1016\/j.jogoh.2022.102409_bib0010","doi-asserted-by":"crossref","first-page":"3460\u20113473","DOI":"10.1200\/JCO.2016.68.6907","article-title":"\u00ab Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline \u00bb","volume":"34","author":"Wright","year":"2016","journal-title":"JCO"},{"issue":"10","key":"10.1016\/j.jogoh.2022.102409_bib0011","doi-asserted-by":"crossref","first-page":"943\u2011953","DOI":"10.1056\/NEJMoa0908806","article-title":"\u00ab Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer \u00bb","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jogoh.2022.102409_bib0012","doi-asserted-by":"crossref","first-page":"1070\u20111076","DOI":"10.1016\/j.ygyno.2006.06.025","article-title":"\u00ab Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis \u00bb","volume":"103","author":"Bristow","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.jogoh.2022.102409_bib0013","doi-asserted-by":"crossref","first-page":"407\u2011412","DOI":"10.1016\/j.ejogrb.2011.07.014","article-title":"\u00ab Optimal timing of interval debulking surgery in advanced ovarian cancer: yet to be defined? \u00bb","volume":"159","author":"Stoeckle","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"10.1016\/j.jogoh.2022.102409_bib0014","doi-asserted-by":"crossref","first-page":"331\u2011340","DOI":"10.1159\/000449203","article-title":"\u00ab Does the Number of Neoadjuvant Chemotherapy Cycles before Interval Debulking Surgery Influence Survival in Advanced Ovarian Cancer? \u00bb","volume":"91","author":"Akladios","year":"2016","journal-title":"Oncology"},{"key":"10.1016\/j.jogoh.2022.102409_bib0015","doi-asserted-by":"crossref","first-page":"22\u201133","DOI":"10.1016\/j.ejca.2016.01.017","article-title":"\u00ab Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome \u00bb","volume":"59","author":"Fagotti","year":"2016","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.jogoh.2022.102409_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186725","article-title":"\u00ab Neoadjuvant chemotherapy versus primary debulking surgery in advanced epithelial ovarian cancer: A meta-analysis of peri-operative outcome \u00bb","volume":"12","author":"Yang","year":"2017","journal-title":"PLoS One"},{"issue":"9990","key":"10.1016\/j.jogoh.2022.102409_bib0017","doi-asserted-by":"crossref","first-page":"249\u2011257","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"\u00ab Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial \u00bb","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jogoh.2022.102409_bib0018","doi-asserted-by":"crossref","first-page":"76\u201182","DOI":"10.1001\/jamaoncol.2016.4411","article-title":"\u00ab Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer: Analysis of the National Cancer Database \u00bb","volume":"3","author":"Rauh-Hain","year":"2017","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.jogoh.2022.102409_bib0019","doi-asserted-by":"crossref","first-page":"1666\u20111673","DOI":"10.1245\/s10434-015-5051-9","article-title":"\u00ab What Should We Expect After a Complete Cytoreduction at the Time of Interval or Primary Debulking Surgery in Advanced Ovarian Cancer? \u00bb","volume":"23","author":"Chiva","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.jogoh.2022.102409_bib0020","doi-asserted-by":"crossref","first-page":"434\u2011441","DOI":"10.1016\/j.ygyno.2020.08.028","article-title":"\u00ab Role of delayed interval debulking for persistent residual disease after more than 5 cycles of chemotherapy for primary advanced ovarian cancer. An international multicenter study \u00bb","volume":"159","author":"Plett","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.jogoh.2022.102409_bib0021","first-page":"29\u201133","article-title":"\u00ab Impact of dose-intense chemotherapy on the development of permanent drug resistance \u00bb","volume":"14","author":"Coldman","year":"1987","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jogoh.2022.102409_bib0022","doi-asserted-by":"crossref","first-page":"127\u2011132","DOI":"10.1016\/j.canlet.2017.03.036","article-title":"\u00ab Rapid selection of BRCA1-proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers \u00bb","volume":"397","author":"Sokolenko","year":"2017","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.jogoh.2022.102409_bib0023","doi-asserted-by":"crossref","first-page":"63\u201168","DOI":"10.1016\/j.ygyno.2013.01.009","article-title":"\u00ab Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma \u00bb","volume":"129","author":"Rauh-Hain","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.jogoh.2022.102409_bib0024","doi-asserted-by":"crossref","first-page":"1856\u20111862","DOI":"10.1097\/IGC.0000000000001108","article-title":"\u00ab The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC-IV Unresectable Ovarian Cancer: Results From a Multi-Institutional Study \u00bb","volume":"27","author":"Bogani","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.jogoh.2022.102409_bib0025","doi-asserted-by":"crossref","first-page":"427\u2011435","DOI":"10.1007\/s00280-004-0993-9","article-title":"\u00ab Neoadjuvant chemotherapy for epithelial ovarian cancer\u2013role of apoptosis \u00bb","volume":"56","author":"Dutta","year":"2005","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"10.1016\/j.jogoh.2022.102409_bib0026","doi-asserted-by":"crossref","first-page":"632.e1\u20118","DOI":"10.1016\/j.ajog.2014.06.034","article-title":"\u00ab Prognostic role and predictors of complete pathologic response to neoadjuvant chemotherapy in primary unresectable ovarian cancer \u00bb","volume":"211","author":"Petrillo","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.jogoh.2022.102409_bib0027","doi-asserted-by":"crossref","first-page":"1337\u20111343","DOI":"10.1097\/IGC.0b013e31826a3559","article-title":"\u00ab Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study \u00bb","volume":"22","author":"Luyckx","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"7","key":"10.1016\/j.jogoh.2022.102409_bib0028","doi-asserted-by":"crossref","first-page":"1104\u20111105","DOI":"10.1097\/IGC.0b013e318265159b","article-title":"\u00ab Comment on \u201cPrimary chemotherapy for inoperable ovarian, fallopian tube, or primary peritoneal cancer with or without delayed debulking surgery\u201d \u00bb","volume":"22","author":"Barton","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.jogoh.2022.102409_bib0029","doi-asserted-by":"crossref","first-page":"660\u2011667","DOI":"10.1016\/j.ygyno.2021.04.012","article-title":"\u00ab Timing of surgery in patients with partial response or stable disease after neoadjuvant chemotherapy for advanced ovarian cancer \u00bb","volume":"161","author":"Nitecki","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"13","key":"10.1016\/j.jogoh.2022.102409_bib0030","doi-asserted-by":"crossref","first-page":"4059\u20114067","DOI":"10.1245\/s10434-012-2446-8","article-title":"\u00ab Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer \u00bb","volume":"19","author":"Chang","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.jogoh.2022.102409_bib0031","doi-asserted-by":"crossref","first-page":"445\u2011451","DOI":"10.1016\/j.ygyno.2019.02.019","article-title":"\u00ab The prognostic value of residual disease after neoadjuvant chemotherapy in advanced ovarian cancer; A systematic review \u00bb","volume":"153","author":"Timmermans","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"9","key":"10.1016\/j.jogoh.2022.102409_bib0032","doi-asserted-by":"crossref","first-page":"822\u2011832","DOI":"10.1056\/NEJMoa1808424","article-title":"\u00ab A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms \u00bb","volume":"380","author":"Harter","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jogoh.2022.102409_bib0033","doi-asserted-by":"crossref","first-page":"230\u2011240","DOI":"10.1056\/NEJMoa1708618","article-title":"\u00ab Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer \u00bb","volume":"378","author":"van Driel","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jogoh.2022.102409_bib0034","doi-asserted-by":"crossref","first-page":"676.e1\u20117","DOI":"10.1016\/j.ajog.2007.10.495","article-title":"\u00ab Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer \u00bb","volume":"197","author":"Aletti","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jogoh.2022.102409_bib0035","series-title":"\u00ab CHRONO - Retarded Surgery Following Neoadjuvant Chemotherapy in Advanced Ovarian Cancer - ARCAGY\/GINECO GROUP - NCT03579394 \u00bb","author":"Classe","year":"2022"}],"container-title":["Journal of Gynecology Obstetrics and Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784722000927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468784722000927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:59:52Z","timestamp":1762855192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468784722000927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2468784722000927"],"URL":"https:\/\/doi.org\/10.1016\/j.jogoh.2022.102409","relation":{},"ISSN":["2468-7847"],"issn-type":[{"value":"2468-7847","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interval debulking surgery after neoadjuvant chemotherapy in advanced ovarian cancer - retrospective study comparing surgery after 3 cycles or more of chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Gynecology Obstetrics and Human Reproduction","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogoh.2022.102409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102409"}}